Enzalutamide, Abiraterone

Drug identity checked against registry records

Also recorded as XTANDI; Zytiga

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting AgentNCT04844749VERUPhase 3Terminated2023-05-04Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.